Interestingly, we found that only DBNDD1 gene expression in the dysbindin protein family was substantially elevated in prostate tumor samples, whereas DTNBP1 and DBNDD2 gene expressions were not. This evidence concerns the gene DBNDD1 and prostate neoplasm.